RSS

Group B Streptococcal (GBS)

Danish biotech company MinervaX has initiated a Phase I clinical trial with its Group B Streptococcal (GBS) vaccine candidate, GBS-NN, targeting pregnant women for the prevention of life-threatening infections in newborns. more

News